Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-24

Clinical Trial Update: Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiotherapy combined with albumin-bound paclitaxel and nedaplatin for locally advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin-bound paclitaxel (nab-paclitaxel)
  • Nedaplatin (nedaplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN